Medical device post-award support checklist: training, SLAs, rollout

title: Medical device post-award support checklist: training, SLAs, rollout description: A procurement-grade checklist for onboarding, training/field education, CAPA flows, QBR cadence, and SLAs after awarding a medical device supplier. slug: medical-device-post-award-support-checklist feature_image: https://statics.myquickcreator.com/upload/aaacq5qoo3ej7hdm/2026/04/24/image_1777023718-cq1gk5vo.jpeg feature_image_alt: Cinematic photo of a medical device supplier onboarding meeting reviewing a medical device post-award support checklist

Winning an award is the easy part. The real risk starts after signature: training doesn’t land in the field, escalation paths are unclear, and quality events move too slowly to protect patients and your timeline.

This medical device post-award support checklist is designed for OEM/ODM and hospital-channel procurement/category leaders. It’s intentionally operational: what to set up, what “done” looks like, and what to measure—without turning into a legal template.

Key Takeaway: If your post-award support isn’t designed as a system (governance + training + CAPA + SLAs), you’ll end up managing surprises instead of performance.

Definitions procurement teams actually use

SLA (Service Level Agreement): the measurable service commitments that make support predictable (response times, escalation, training lead times, replacement/credit terms, audit response).

CAPA (Corrective and Preventive Action): the structured way to investigate issues, fix root causes, and verify the fix worked. FDA covers CAPA basics in FDA’s Corrective and Preventive Action (CAPA) Basics.

Complaint handling: the intake + evaluation + investigation process for complaints. FDA outlines expectations in FDA’s Complaint Files training slides.

QBR (Quarterly Business Review): a structured governance meeting to review KPIs, risks, and improvement actions—before issues escalate.

What a medical device post-award support checklist should cover

At a minimum, a workable support model has four properties:

1. Documented responsibilities (who owns what, across procurement/quality/supply chain/sales).

2. Time-bound workflows (not “we’ll get back to you,” but “within X days, we’ll do Y”).

3. Field education that actually reaches end users (not just a slide deck sent by email).

4. A cadence that converts data into action (QBRs + dashboards + CAPA effectiveness checks).

If you want a benchmark for governance structures, consultancies often recommend formal committees, KPI dashboards, and escalation ladders (see the governance artifacts summarized in Umbrex’s vendor selection and contracting guide).

Phase 1 — Contracting checklist: lock the operating system into the contract

Use this section when you’re finalizing MSA/SOW and a Supplier Quality Agreement (SQA) or Quality/Technical Agreement.

Contracting checklist (Yes/No)

1. Do we have an SQA/QTA that defines complaint intake, investigation responsibilities, and CAPA expectations?

2. Is there a “no-change” notification clause (product, process, facility, key materials, sterilization changes) with lead times and approval steps?

3. Are audit rights and audit-response timelines explicit (including who supplies records and within what window)?

4. Do SLAs define response + escalation for quality events and supply disruptions (not just a generic support email)?

5. Do we have a defined documentation pack (certifications, quality manual excerpt, traceability/lot documentation outline, sterilization documentation where applicable)?

6. Are remedies defined for material SLA breaches (e.g., expedited replacement, credit terms, or other agreed mechanisms)?

7. Is there a named escalation ladder from working team → management → executive sponsor?

⚠️ Warning: “We’ll work it out as we go” is not flexibility. It’s an unpriced risk.

Phase 2 — Supplier onboarding checklist: make support usable on day one

Onboarding is where post-award support becomes real. Don’t confuse “kickoff meeting held” with “support operational.”

Onboarding checklist (Yes/No)

1. Do we have a kickoff pack with owners and dates (contacts, escalation ladder, cadence, doc list, first-ship plan)?

2. Is training scoped by role (clinical end users vs. distributor sales reps vs. internal customer service vs. QA/RA interfaces)?

3. Is there a field education roadmap with milestones (pilot training → launch training → refreshers → new-hire onboarding)?

4. Have we defined what training completion means (attendance + competency check, not only “slides delivered”)?

5. Is the complaint/CAPA intake route tested (who receives, how to classify, what data is required, where it’s logged)?

6. Are sample and validation needs planned (complimentary samples, labeling mockups, packaging approvals) before rollout dates?

7. Have we agreed how to handle urgent recalls/field actions and reportable events in the relevant markets?

For EU vigilance/PMS framing, see TÜV SÜD’s MDR Chapter VII overview. If you need a supplier-facing summary of EU compliance expectations, SLK Medical also publishes a plain-language overview of CE MDR certified wound dressings.

Phase 3 — Launch and rollout checklist: prevent “field drift”

Rollout is where training meets reality: stocking patterns, dressing selection behavior, documentation requests, and early complaints.

Rollout checklist (Yes/No)

1. Is there a launch-week hypercare window with defined contacts and response targets?

2. Is field education scheduled, not optional (in-person when needed; otherwise structured remote sessions with Q&A)?

3. Do we have a standard “first 10 cases” feedback loop (what went wrong, what questions keep repeating, what needs a job aid)?

4. Are labeling and packaging controls in place (private label proofs, artwork version control, market-specific requirements)?

5. Is the quality-event triage defined (severity bands, escalation triggers, timelines)?

6. Is inventory and lead-time monitoring active (OTIF, backorders, constraints, mitigation options)?

7. Is there a plan for process adherence across regions (US vs EU differences in documentation requests and reporting)?

Example (brand integration in an allowed zone)

As a concrete reference point, SLK Medical communicates several operational commitments relevant to rollout planning—such as bulk orders delivered within 30 days, monthly capacity of 10 million units, and support for complimentary samples and OEM services. See the SLK Medical site for broader context on quality expectations and certifications, including foam dressing supplier standards and certifications and manufacturing reliability framing in silicone foam dressing manufacturer reliability and pricing.

Phase 4 — Steady-state checklist: governance that keeps improving (not just reporting)

This is the part most teams underfund: you need a cadence that converts data into decisions.

Steady-state checklist (Yes/No)

1. Is there a QBR cadence with a locked agenda (not “as needed”)?

2. Do we have an SLA scorecard dashboard with thresholds and escalation triggers?

3. Are CAPAs tracked to closure with effectiveness checks (not just “action taken”)?

4. Is change control monitored continuously (materials, process, facility, sterilization, packaging)?

5. Do we have audit readiness rehearsals (document retrieval time, traceability drill, batch record completeness)?

6. Is the field education program maintained (refresher cadence, new-hire onboarding, updated job aids)?

7. Is continuous improvement resourced (owners, timelines, and a backlog of fixes)?

Copy/paste templates you can reuse

1) Post-award SLA scorecard (example)

2) CAPA + complaint handling flow (high-level)

1. Intake (log complaint; collect required details)

2. Triage (classify severity; decide investigation scope)

3. Containment (immediate actions to protect patients and supply continuity)

4. Investigation (root cause analysis; confirm scope)

5. CAPA plan (corrective + preventive actions with owners and dates)

6. Implementation (execute changes; document)

7. Effectiveness check (verify the fix worked; watch recurrence)

8. Closure + learning (update training, work instructions, risk files)

For a regulatory framing of what FDA expects to see documented, review FDA’s CAPA basics and FDA’s complaint files slides.

3) QBR agenda (60 minutes)

• 5 min — KPI snapshot (OTIF, lead time, complaints, CAPA aging)

• 10 min — SLA breaches and escalations (what happened, containment)

• 15 min — Quality trends (top failure modes, investigation themes)

• 10 min — Change control log (planned and recent changes)

• 10 min — Training / field education metrics (coverage, competency, new assets)

• 10 min — Improvement plan (next quarter actions + owners)

Key takeaways

• Post-award support is a system: governance + training + CAPA + SLAs.

• Make “done” binary during onboarding—otherwise you’re counting meetings, not readiness.

• Put escalation and response windows in writing before launch.

• Use a QBR cadence to keep issues small and measurable.

FAQ

What should be in a medical device supplier’s post-award SLA?

At minimum: response times for quality inquiries, complaint triage windows, CAPA containment timelines, audit-response timelines, lead-time commitments, and escalation triggers.

How do CAPA and complaint handling relate?

Complaints are one of the most common triggers for CAPA. Complaint handling captures the issue; CAPA is how you prevent recurrence.

How often should we run QBRs with an OEM/ODM supplier?

Quarterly is a common baseline for stable supply. High-risk categories or new launches may require monthly operational reviews during the first quarter, then step down to QBR.

Next steps (low-commitment)

If you want, we can turn this into a one-page “post-award support pack” for your team: SLA scorecard + QBR agenda + CAPA RACI in a procurement-ready format.